THRIVENT FINANCIAL FOR LUTHERANS - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$317
-67.2%
149,690
-52.1%
0.00%
-50.0%
Q2 2023$967
-43.0%
312,652
-0.8%
0.00%
-50.0%
Q1 2023$1,696
-16.9%
315,209
+2.7%
0.00%
-20.0%
Q4 2022$2,040
-99.8%
306,811
+1.5%
0.01%
+66.7%
Q3 2022$1,204,000
-15.6%
302,412
+5.4%
0.00%
-25.0%
Q2 2022$1,426,000
-22.8%
286,852
-6.2%
0.00%0.0%
Q1 2022$1,847,000
-48.1%
305,825
-0.1%
0.00%
-42.9%
Q4 2021$3,558,000
-25.3%
306,143
+0.8%
0.01%
-30.0%
Q3 2021$4,764,000
-8.3%
303,798
+9.1%
0.01%
-9.1%
Q2 2021$5,194,000
-56.6%
278,480
+0.3%
0.01%
-57.7%
Q1 2021$11,972,000277,7770.03%
Other shareholders
VOR BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$73,923,00013.88%
RA Capital Management 11,120,973$129,226,0002.28%
Paradigm Biocapital Advisors LP 629,342$7,313,0002.09%
OUP Management Co., LLC 374,714$4,354,0001.96%
JOHNSON & JOHNSON 1,074,658$12,488,0001.42%
Sarissa Capital Management LP 707,010$8,215,0000.71%
Woodline Partners LP 1,111,123$12,911,0000.18%
Artal Group S.A. 550,000$6,391,0000.17%
Orbimed Advisors 833,333$9,683,0000.12%
Laurion Capital Management LP 857,308$9,962,0000.10%
View complete list of VOR BIOPHARMA INC shareholders